Biologic Hernia Repair Mesh Market Expected to Hit $2.46 Billion by 2029, Growing at 7.3% CAGR
Save 20% on All Global Market Reports With Code ONLINE20 — Gain Insights Into Tariffs, Inflation, and Industry Trends
What Is the Growth Potential of the Biologic Hernia Repair Mesh Market in the Next Decade?
The biologic hernia repair mesh market size has grown strongly in recent years. It will grow from $1.71 billion in 2024 to $1.85 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rising healthcare expenditure, growing clinical evidence supporting efficacy, rising demand for customized and patient-specific implants, increasing adoption in veterinary and pediatric surgeries, and rising burden of obesity and lifestyle-related disorders.
The biologic hernia repair mesh market size is expected to see strong growth in the next few years. It will grow to $2.46 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing prevalence of hernia cases, growing adoption of advanced biologic implants, a rising geriatric population, increasing preference for minimally invasive surgeries, and growing awareness about post-surgical complications. Major trends in the forecast period include advancements in tissue engineering technologies, development of next-generation biologic scaffolds, technological improvements in decellularization processes, advancements in bioresorbable material science, and development of composite biologic-synthetic meshes.
Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25708&type=smp
What Are the Key Growth Factors Supporting the Biologic Hernia Repair Mesh Market Expansion?
The increasing incidence of hernia cases is expected to propel the growth of the biologic hernia repair mesh market going forward. Hernia cases refer to the number of instances involving the abnormal protrusion of an internal organ or tissue through a weakened area in the muscle or connective tissue. The rise in hernia cases is attributed to growing obesity rates, as excess body weight exerts increasing pressure on abdominal muscles, thereby elevating the risk of hernia formation. Biologic hernia repair mesh aids in treating hernia cases by offering a scaffold composed of natural tissue that facilitates healing, integrates with the patient’s body, and minimizes the likelihood of rejection or persistent inflammation. For instance, in July 2024, according to Eurostat, a Luxembourg-based government agency, repairs of inguinal hernia were typically performed between 142 and 231 times per 100,000 inhabitants in 2022, with Austria reporting a notably higher rate of 273.2 per 100,000 inhabitants. Therefore, the increasing incidence of hernia cases is driving the growth of the biologic hernia repair mesh market.
Which Segments Are Attracting Maximum Investment in the Biologic Hernia Repair Mesh Market?
The biologic hernia repair mesh market covered in this report is segmented —
1) By Type: Partially Absorbable Hernia Repair Mesh, Fully Absorbable Hernia Repair Mesh
2) By Product Type: Porcine, Bovine, Human Dermis, Other Product Types
3) By Distribution Channel: Direct Sales, Distributors, Online Sales, Pharmacies
4) By Application: Inguinal Hernia Repair, Ventral Hernia Repair, Umbilical Hernia Repair, Other Hernia Repairs
5) By End-User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End Users
Subsegments:
1) By Partially Absorbable Hernia Repair Mesh: Composite Mesh, Reinforced Biologic Mesh
2) By Fully Absorbable Hernia Repair Mesh: Extracellular Matrix (Ecm) Mesh, Acellular Dermal Matrix (Adm) Mesh
What Are the Significant Trends in the Biologic Hernia Repair Mesh Market Across Regions?
Major companies operating in the biologic hernia repair mesh market are focusing on developing innovative solutions, such as reinforced biologic mesh, to enhance strength, flexibility, and integration with host tissue. Reinforced biologic mesh is a type of surgical mesh that combines biologic tissue with synthetic fibers to enhance durability, support tissue regeneration, and minimize hernia recurrence. For instance, in April 2024, TELA Bio Inc., a US-based medical technology company, introduced OviTex inguinal hernia repair (IHR), a reinforced biologic mesh option for inguinal hernia repair. It is a reinforced tissue matrix specifically designed for laparoscopic and robotic inguinal hernia procedures, leveraging a combination of biologic ovine extracellular matrix (ECM) and minimal synthetic polymer to deliver strength, facilitate rapid tissue integration, and reduce the risk of complications. Its advantages include lower recurrence rates, accelerated healing, and higher patient satisfaction, effectively overcoming the drawbacks associated with conventional synthetic meshes.
Which Major Companies Are Operating in the Biologic Hernia Repair Mesh Market?
Major companies operating in the biologic hernia repair mesh market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company, DSM Biomedical, Baxter International Inc., W. L. Gore & Associates Inc., Meril Life Sciences, Cook Medical LLC, Integra LifeSciences Corporation, MTF Biologics, LifeCell Corporation, AlloSource, TELA Bio Inc., Kerecis, Assut Europe S.p.A., Serag-Wiessner GmbH & Co. KG, Aroa Biosurgery Limited, ACell Inc., Tissue Regenix Group plc., RTI Surgical Inc., Beijing Datsing Bio-Tech Co. Ltd., Shanghai Pine & Power Biotech Co. Ltd.
Get the full biologic hernia repair mesh market report here:
https://www.thebusinessresearchcompany.com/report/biologic-hernia-repair-mesh-global-market-report
How Is Regional Performance Expected to Affect Biologic Hernia Repair Mesh Market Growth?
North America was the largest region in the biologic hernia repair mesh market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic hernia repair mesh market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Americas +1 310–496–7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment